Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection

Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther. 2005;21(6):653-662.

Publication Type:

Journal Article

Authors:

Gisbert, J.P.; Garcia-Buey, L.; Pajares, J.M.; Moreno-Otero, R.

Source:

Aliment Pharmacol Ther, Volume 21, Issue 6, p.653-662 (2005)

Keywords:

Antiviral Agents, drug therapy, eradication, Gastroenterology, Gene Order, Genes,bcl-2, genetics, HCV, hepatitis, Hepatitis C, hepatitis C virus, Humans, Infection, interferon, Interferon-alpha, Liver, Liver Function Tests, Lymphoma, Lymphoproliferative Disorders, methods, Patients, Remission Induction, Research, Research Support, Ribavirin, Role, Spain, strategies, systematic review, therapeutic use, therapy, treatment, virology

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/15771751

Export Citation:

RIS Format

Top